EligibleTrials

Clinical trials recruiting for Malignant Solid Neoplasm

30
Recruiting trials
51
US states with sites
6
Countries
33%
Accept healthy volunteers

Phase breakdown

Phase 1 3Phase 2 3Not applicable 24

Drugs and treatments being studied

InterventionTrials
Nivolumab2
Atezolizumab1
Cabozantinib1
Cabozantinib S-malate1
Cancer Therapeutic Procedure1
Fluorescein Sodium Injection1
Fluoropyrimidine1
Infliximab1
Ipilimumab1
Nab-paclitaxel1
Platinum Compound1
Platinum Doublet1

Where trials are recruiting (top US states)

StateRecruiting trials
California10
Texas10
Florida8
Ohio6
Maryland5
Michigan5
Minnesota5
New York5
District of Columbia4
Illinois4
Missouri4
Virginia4

Top cities

Houston, Texas 10Jacksonville, Florida 6Columbus, Ohio 5Baltimore, Maryland 4Bethesda, Maryland 4Chicago, Illinois 4Detroit, Michigan 4Duarte, California 4Kansas City, Missouri 4New York, New York 4

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Malignant Solid Neoplasm often also study these conditions. Each links to its own recruiting-trial list.

Breast cancer 2239Lung cancer 2180Hematopoietic and Lymphoid Cell Neoplasm 9Prostate cancer 1234Melanoma 487Anxiety 1237Hematopoietic and Lymphatic System Neoplasm 9Breast Carcinoma 74Lung Carcinoma 30Prostate Carcinoma 35

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Malignant Solid Neoplasm trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.